Clinical Outcome of Relapsed or Refractory Burkitt Lymphoma and Mature B-Cell Lymphoblastic Leukemia in Children and Adolescents

PURPOSE: Despite the rapid improvement in survival rate from Burkitt lymphoma and mature B-cell lymphoblastic leukemia (B-ALL) in children, a small subset of patients do not respond to first-line chemotherapy or experience relapse (RL). Herein, we report the clinical characteristics and outcomes of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyery, Park, Eun Sil, Lee, Soo Hyun, Koo, Hong Hoe, Kim, Hyo Sun, Lyu, Chuhl Joo, Jun, So Eun, Lim, Young Tak, Baek, Hee Jo, Kook, Hoon, Lee, Ji Won, Kang, Hyoung Jin, Park, Kyung Duk, Shin, Hee Young, Ahn, Hyeo Seop
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206068/
https://www.ncbi.nlm.nih.gov/pubmed/25043820
http://dx.doi.org/10.4143/crt.2013.047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206068/
https://www.ncbi.nlm.nih.gov/pubmed/25043820
http://dx.doi.org/10.4143/crt.2013.047

Ejemplares similares